Colin McGuckin

Director and Founder @Ctibiotech

Lyon, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2010 — Present

Director and Founder @Ctibiotech

View department →

Lyon, FR

CTI Biotech creates, commercialises and exploits regenerative medicine technologies. Partnering with global corporations and participating in contract research.

EDUCATION

N/A

Ulster University

BSc (Hons) FIRST CLASS, Biology, Biomedicine

N/A

Ulster University

BSc (Hons) FIRST CLASS, Chemistry, Science

N/A

Ulster University

D.Phil (honours PhD system), Oncology and Cancer Biology

1989 — 1989

University of Pittsburgh School of Medicine

Doctor of Philosophy - PhD Internship, UPMC Hillman Cancer Center (formerly the University of Pittsburgh Cancer Institute)

ABOUT COLIN MCGUCKIN

Specialties: Innovation in Science and Medicine - the first Full Professor of Regenerative Medicine in the UK and now founder/CSO of CTIBIOTECH. Specialist in Cancer Research, but also working in: Bioprinting. Stem Cells. Cord Blood. Haematology. Immunology. Clinical trials. Medical Device development. Education. Media. Journalism. Governmental work. Editorial. Regenerative Medicine. Cell Therapies. Cosmetics testing. 3R\'s research. Ethics in human research. Promoting science to schools.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Colin McGuckin — Director and Founder at Ctibiotech in Lyon, FR | Unifers